Wedmont Private Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $777K | Buy |
10,968
+96
| +0.9% | +$6.8K | 0.03% | 327 |
|
|
2025
Q1 | $721K | Buy |
10,872
+317
| +3% | +$21K | 0.04% | 287 |
|
|
2024
Q4 | $707K | Buy |
10,555
+38
| +0.4% | +$2.55K | 0.04% | 292 |
|
|
2024
Q3 | $808K | Buy |
10,517
+892
| +9% | +$68.6K | 0.05% | 247 |
|
|
2024
Q2 | $763K | Buy |
9,625
+674
| +8% | +$53.4K | 0.05% | 249 |
|
|
2024
Q1 | $612K | Buy |
8,951
+1,081
| +14% | +$73.9K | 0.04% | 280 |
|
|
2023
Q4 | $545K | Buy |
7,870
+1,188
| +18% | +$82.2K | 0.04% | 285 |
|
|
2023
Q3 | $448K | Buy |
6,682
+1,351
| +25% | +$90.6K | 0.05% | 279 |
|
|
2023
Q2 | $359K | Buy |
5,331
+160
| +3% | +$10.8K | 0.04% | 335 |
|
|
2023
Q1 | $373K | Buy |
5,171
+211
| +4% | +$15.2K | 0.05% | 279 |
|
|
2022
Q4 | $351K | Buy |
4,960
+538
| +12% | +$38.1K | 0.05% | 299 |
|
|
2022
Q3 | $243K | Buy |
4,422
+174
| +4% | +$9.56K | 0.05% | 311 |
|
|
2022
Q2 | $281K | Buy |
4,248
+1,061
| +33% | +$70.2K | 0.06% | 252 |
|
|
2022
Q1 | $212K | Buy |
+3,187
| New | +$212K | 0.05% | 304 |
|